Conditions: Non-valvular Atrial Fibrillation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1217
Healthy volunteers: no

Brief summary:
The study purpose is to assess the impact of an educational program on patient adherence in patients taking Apixaban for SPAF at 24 weeks

Detailed description:
SPAF=Stroke Prevention in Atrial Fibrillation

ISTH=International Society on Thrombosis and Hemostasis

Primary Purpose: Other: To measure adherence to the study medication using an electronic monitoring device over the first 24 weeks on study medication

Arms:
arm 1: Apixaban 2.5 mg or 5 mg by mouth twice daily for 48 weeks and Primary Standard of Care (SOC) information arm 2: Apixaban 2.5 mg or 5 mg by mouth twice daily for 48 weeks and Additional Educational Program

Interventions: intervention 1: Apixaban
Intervention descriptions: intervention 1: None

Protocol document: